333 related articles for article (PubMed ID: 26118952)
1. Targeting the inflammasome in rheumatic diseases.
McCoy SS; Stannard J; Kahlenberg JM
Transl Res; 2016 Jan; 167(1):125-37. PubMed ID: 26118952
[TBL] [Abstract][Full Text] [Related]
2. Inflammasomes and rheumatic diseases: evolving concepts.
Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
[TBL] [Abstract][Full Text] [Related]
3. Targeting inflammasomes in rheumatic diseases.
So A; Ives A; Joosten LA; Busso N
Nat Rev Rheumatol; 2013 Jul; 9(7):391-9. PubMed ID: 23670136
[TBL] [Abstract][Full Text] [Related]
4. Flavonoids: Nutraceuticals for Rheumatic Diseases via Targeting of Inflammasome Activation.
Yi YS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33418975
[TBL] [Abstract][Full Text] [Related]
5. Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases.
Deuteraiou K; Kitas G; Garyfallos A; Dimitroulas T
Rheumatol Int; 2018 Aug; 38(8):1345-1354. PubMed ID: 29869008
[TBL] [Abstract][Full Text] [Related]
6. Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
Shin JI; Lee KH; Joo YH; Lee JM; Jeon J; Jung HJ; Shin M; Cho S; Kim TH; Park S; Jeon BY; Jeong H; Lee K; Kang K; Oh M; Lee H; Lee S; Kwon Y; Oh GH; Kronbichler A
J Autoimmun; 2019 Sep; 103():102299. PubMed ID: 31326231
[TBL] [Abstract][Full Text] [Related]
7. Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge.
Yang CA; Chiang BL
Clin Rev Allergy Immunol; 2021 Oct; 61(2):156-170. PubMed ID: 33236284
[TBL] [Abstract][Full Text] [Related]
8. Inflammasome-independent regulation of IL-1-family cytokines.
Netea MG; van de Veerdonk FL; van der Meer JW; Dinarello CA; Joosten LA
Annu Rev Immunol; 2015; 33():49-77. PubMed ID: 25493334
[TBL] [Abstract][Full Text] [Related]
9. Perception of self: distinguishing autoimmunity from autoinflammation.
van Kempen TS; Wenink MH; Leijten EF; Radstake TR; Boes M
Nat Rev Rheumatol; 2015 Aug; 11(8):483-92. PubMed ID: 25963881
[TBL] [Abstract][Full Text] [Related]
10. A novel synthetic derivative of melatonin, 5-hydroxy-2'-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation.
Shim DW; Shin HJ; Han JW; Ji YE; Jang CH; Koppula S; Kang TB; Lee KH
Toxicol Appl Pharmacol; 2015 Apr; 284(2):227-35. PubMed ID: 25689174
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases.
Abderrazak A; Syrovets T; Couchie D; El Hadri K; Friguet B; Simmet T; Rouis M
Redox Biol; 2015; 4():296-307. PubMed ID: 25625584
[TBL] [Abstract][Full Text] [Related]
12. [The inflammasome].
Okumura C; Haraikawa K; Suehiro S; Ito Y; Masumoto J
Nihon Rinsho; 2013 Aug; 71(8):1497-504. PubMed ID: 23967686
[TBL] [Abstract][Full Text] [Related]
13. The inflammasome and IL-1β: implications for the treatment of inflammatory diseases.
Satoh T; Otsuka A; Contassot E; French LE
Immunotherapy; 2015; 7(3):243-54. PubMed ID: 25804477
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of the inflammasome: keeping inflammation under control.
Pedraza-Alva G; Pérez-Martínez L; Valdez-Hernández L; Meza-Sosa KF; Ando-Kuri M
Immunol Rev; 2015 May; 265(1):231-57. PubMed ID: 25879297
[TBL] [Abstract][Full Text] [Related]
15. Role of inflammasomes in inflammatory autoimmune rheumatic diseases.
Yi YS
Korean J Physiol Pharmacol; 2018 Jan; 22(1):1-15. PubMed ID: 29302207
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms regulating NLRP3 inflammasome activation.
Jo EK; Kim JK; Shin DM; Sasakawa C
Cell Mol Immunol; 2016 Mar; 13(2):148-59. PubMed ID: 26549800
[TBL] [Abstract][Full Text] [Related]
17. Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases.
Zhong Z; Sanchez-Lopez E; Karin M
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):12-6. PubMed ID: 27586797
[TBL] [Abstract][Full Text] [Related]
18. The inflammasomes in kidney disease.
Anders HJ; Muruve DA
J Am Soc Nephrol; 2011 Jun; 22(6):1007-18. PubMed ID: 21566058
[TBL] [Abstract][Full Text] [Related]
19. The pathogenic role of the inflammasome in neurodegenerative diseases.
Freeman LC; Ting JP
J Neurochem; 2016 Jan; 136 Suppl 1():29-38. PubMed ID: 26119245
[TBL] [Abstract][Full Text] [Related]
20. Primer: inflammasomes and interleukin 1beta in inflammatory disorders.
Church LD; Cook GP; McDermott MF
Nat Clin Pract Rheumatol; 2008 Jan; 4(1):34-42. PubMed ID: 18172447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
